21 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
8 Sep 21
Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating
8:31am
exploring the potential of CBP-201 in patients with atopic dermatitis and asthma, and reinforces our commitment to developing treatment solutions
F-1
EX-10.1
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
or commitment in an act of theft, embezzlement, fraud, or a breach of trust, (iv) any intentional misconduct or material breach of any labor contract … , Director or Consultant who receives an Award under the Plan.
(w) “IPO” shall mean the Company’s first firm commitment underwritten public offering
DRS
EX-10.1
CNTB
Connect Biopharma Holdings Ltd
17 Dec 20
Draft registration statement
12:00am
) dishonesty or commitment in an act of theft, embezzlement, fraud, or a breach of trust, (iv) any intentional misconduct or material breach of any labor … an Employee, Director or Consultant who receives an Award under the Plan.
(w) “IPO” shall mean the Company’s first firm commitment underwritten
6-K
CNTB
Connect Biopharma Holdings Ltd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
were cancelled. In relation to the share surrender, the Company did not enter into any agreement or commitment for future consideration … for no consideration. The surrendered shares were cancelled. In relation to the share surrender, the Company did not enter into any agreement or commitment
CORRESP
CNTB
Connect Biopharma Holdings Ltd
8 Mar 21
Correspondence with SEC
12:00am
management’s and the Board of Director’s commitment of going through with the IPO. However, there continued to be significant uncertainties
DRS
EX-3.1
8wqj wpyisbgkaoin3d
17 Dec 20
Draft registration statement
12:00am
F-1
EX-3.1
sl26ut1v32 1n
26 Feb 21
Registration statement (foreign)
4:56pm
6-K
0o6hl
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
F-1
EX-4.4
rs7qyrlwm92 b6ftz3jr
26 Feb 21
Registration statement (foreign)
4:56pm
DRS
EX-4.4
c97kb mern85bo
17 Dec 20
Draft registration statement
12:00am
F-1/A
EX-10.3
dn8 zo5xy
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-10.3
9c0obownhj
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
424B4
j278k
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
ndryvvd3ayclt4m
18 Mar 21
Registration statement (foreign) (amended)
6:15am
DRS/A
o5qf96l 1u
26 Jan 21
Draft registration statement (amended)
12:00am
20-F
rvxrkz civrved
31 Mar 22
Annual report (foreign)
4:33pm
F-1/A
unju1vbbv8q x36jbv0d
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
tbba7yl46c1avwzyo8q2
26 Feb 21
Registration statement (foreign)
4:56pm